Skip to main content

Table 2 Echocardiographic characteristics of study population at the indexed event

From: Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up

 

Overall (N = 134)

RTF (N = 40)

No FTR (N = 94)

Mild FTR (N = 8)

Moderate FTR (N = 25)

Severe FTR (N = 7)

p value for Trend

95% CI range

LA Area, mm

38 ± 8.8

46.3 ± 8.06

35 ± 6.89

45.13 ± 8.14

46 ± 8.73

48 ± 5.5

 < 0.0001

[− 0.01–0.02]

LVIDD, mm

55 ± 6.2

59.2 ± 3.9

53 ± 6.1

59 ± 1.9

58 ± 4.7

60 ± 1.8

 < 0.0001

[0.00–0.03]

LVEF, %

46 ± 9.4

37 ± 6.4

50 ± 7.3

43 ± 3.2

37 ± 5.2

28 ± 2.7

 < 0.0001

[− 0.02–0.00]

RV FAC, %

28 ± 5.4

22.2 ± 4.3

30 ± 3.6

23 ± 5.0

21 ± 4.4

22 ± 3.8

 < 0.0001

[− 0.06–0.01]

RV dysfunction > 2, n (%)

33 (24)

30 (75)

3 (3.2)

5 (62.5)

20 (80)

5 (71.4)

 < 0.0001

[0.46–0.06]

Mean sPAP, mm Hg

36 ± 10.8

48.2 ± 9.4

32 ± 7.1

34 ± 6.4

46 ± 4.6

59 ± 5.3

 < 0.0001

[0.01–0.03]

PHT ≥ Moderate, n (%)

33 (24.6)

32 (80)

3 (3.2)

5 (62.5)

20 (80)

5 (71.4)

 < 0.0001

[0.0–0.62]

MR > 2, n (%)

47 (35.1)

39 (97.5)

8 (8.5)

7 (87.5)

25 (100)

7 (100)

 < 0.0001

[− 0.3–0.39]

  1. Overall and by FTR development grade
  2. R = .395, R2 = .874. The Highest Beta coefficient was observed in LVEF (.396) and RV dysfunction > 2 (.206). No multicollinearity was observed
  3. LVIDD indicates left ventricular internal diameter at end-diastolic phase; LVEF left ventricular ejection fraction; RV FAC, Right ventricular fractional area change; sPAP, systolic pulmonary artery pressure; PHT, Pulmonary Hypertension; MR, mitral regurgitation